EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update

Ultrasonography in the assessment of disease activity in cranial and large-vessel giant cell arteritis: a prospective follow-up study

(2023) Berit D Nielsen et al.   RHEUMATOLOGY

Norwegian society of rheumatology recommendations on diagnosis and treatment of patients with giant cell arteritis

(2023) Anne Bull Haaversen et al.   Frontiers in Medicine

OP0188 IMAGING IN DIAGNOSIS, MONITORING AND OUTCOME PREDICTION OF LARGE VESSEL VASCULITIS: A SYSTEMATIC LITERATURE REVIEW INFORMING THE 2023 UPDATE OF THE EULAR RECOMMENDATIONS

(2023) P. Bosch et al.   ANNALS OF THE RHEUMATIC DISEASES

What is a response in randomised controlled trials in giant cell arteritis?

(2023) Christian Dejaco et al.   ANNALS OF THE RHEUMATIC DISEASES

Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica

(2023) Christian Dejaco et al.   ANNALS OF THE RHEUMATIC DISEASES

The effectiveness of tocilizumab and its comparison with tumor necrosis factor alpha inhibitors for Takayasu Arteritis: A systematic review and meta-analysis

(2023) Durga Prasanna Misra et al.   AUTOIMMUNITY REVIEWS

Disease stratification in GCA and PMR: state of the art and future perspectives

(2023) Alessandro Tomelleri et al.   Nature Reviews Rheumatology

Large-vessel vasculitis

(2022) Dan Pugh et al.   Nature Reviews Disease Primers

The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis

(2022) N. Ughi et al.   Reumatismo

The role of PET/CT in disease activity assessment in patients with large vessel vasculitis

(2022) Elena Galli et al.   RHEUMATOLOGY

Validity of the EULAR recommendations on the use of ultrasound in the diagnosis of giant cell arteritis

(2022) Elisa Fernández-Fernández et al.   RMD Open

LB0006 SARILUMAB IN PATIENTS WITH RELAPSING POLYMYALGIA RHEUMATICA: A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED TRIAL (SAPHYR)

(2022) B. Dasgupta et al.   ANNALS OF THE RHEUMATIC DISEASES

Implementation of recommendations in rheumatic and musculoskeletal diseases: considerations for development and uptake

(2022) Estibaliz Loza et al.   ANNALS OF THE RHEUMATIC DISEASES

Follow-up Contrast-Enhanced Ultrasonography of the Carotid Artery in Patients With Takayasu Arteritis: A Retrospective Study

(2022) Jin Ding et al.   JOURNAL OF RHEUMATOLOGY

Spectrum of Large- and Medium-Vessel Vasculitis in Adults: Neoplastic, Infectious, Drug-Induced, Autoinflammatory, and Primary Immunodeficiency Diseases

(2022) Fabian Lötscher et al.   Current Rheumatology Reports

Association of 18F‐Fluorodeoxyglucose Positron Emission Tomography and Angiographic Progression of Disease in Large‐Vessel Vasculitis

(2022) Kaitlin A. Quinn et al.   Arthritis & Rheumatology

Spectrum of Large and Medium Vessel Vasculitis in Adults: Primary Vasculitides, Arthritides, Connective Tissue, and Fibroinflammatory Diseases

(2022) Luca Seitz et al.   Current Rheumatology Reports

Ultrasound intima media thickness cut-off values for cranial and extracranial arteries in patients with suspected giant cell arteritis

(2022) Katerine López-Gloria et al.   Frontiers in Medicine

The provisional OMERACT ultrasonography score for giant cell arteritis

(2022) Christian Dejaco et al.   ANNALS OF THE RHEUMATIC DISEASES

Intima-media thickness cut-off values depicting “halo sign” and potential confounder analysis for the best diagnosis of large vessel giant cell arteritis by ultrasonography

(2022) Marcin Milchert et al.   Frontiers in Medicine

Characterization of visual manifestations and identification of risk factors for permanent vision loss in patients with giant cell arteritis

(2021) Hussein Baalbaki et al.   CLINICAL RHEUMATOLOGY

OMERACT Definition and Reliability Assessment of Chronic Ultrasound Lesions of the Axillary Artery in Giant Cell Arteritis

(2021) Valentin S. Schäfer et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Comparing Semi-quantitative and Qualitative Methods of Vascular FDG-PET Activity Measurement in Large-Vessel Vasculitis

(2021) Himanshu R Dashora et al.   JOURNAL OF NUCLEAR MEDICINE

Quantitative ultrasound to monitor the vascular response to tocilizumab in giant cell arteritis

(2021) Luca Seitz et al.   RHEUMATOLOGY

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis

(2021) Mehrdad Maz et al.   ARTHRITIS CARE & RESEARCH

Tocilizumab monotherapy after ultra-short glucocorticoid administration in giant cell arteritis: a single-arm, open-label, proof-of-concept study

(2021) Lisa Christ et al.   Lancet Rheumatology

Increased risk of thoracic aortic complications among patients with giant cell arteritis: a nationwide, population-based cohort study

(2021) Philip Therkildsen et al.   RHEUMATOLOGY

Disease stratification in giant cell arteritis to reduce relapses and prevent long-term vascular damage

(2021) Alessandro Tomelleri et al.   Lancet Rheumatology

Diagnostic accuracy of vascular ultrasound in patients with suspected giant cell arteritis (EUREKA): a prospective, multicentre, non-interventional, cohort study

(2021) Stavros Chrysidis et al.   Lancet Rheumatology

Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia

(2020) Kornelis S M van der Geest et al.   ANNALS OF THE RHEUMATIC DISEASES

Cranial and large vessel activity on positron emission tomography scan at diagnosis and 6 months in giant cell arteritis

(2020) Anthony M. Sammel et al.   International Journal of Rheumatic Diseases

British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis: executive summary

(2020) Sarah L Mackie et al.   RHEUMATOLOGY

Early variation of ultrasound halo sign with treatment and relation with clinical features in patients with giant cell arteritis

(2020) Cristina Ponte et al.   RHEUMATOLOGY

Visual and semiquantitative assessment of cranial artery inflammation with FDG-PET/CT in giant cell arteritis

(2020) Pieter H Nienhuis et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

The cut-off values for the intima–media complex thickness assessed by colour Doppler sonography in seven cranial and aortic arch arteries

(2020) Rok Ješe et al.   RHEUMATOLOGY

Use of 18F-fluorodeoxyglucose positron emission tomography to monitor tocilizumab effect on vascular inflammation in giant cell arteritis

(2020) Kaitlin A Quinn et al.   RHEUMATOLOGY

Ultrasonographic Halo Score in giant cell arteritis: association with intimal hyperplasia and ischaemic sight loss

(2020) Kornelis S M van der Geest et al.   RHEUMATOLOGY

Fast-Track Ultrasound Clinic for the Diagnosis of Giant Cell Arteritis Changes the Prognosis of the Disease but Not the Risk of Future Relapse

(2020) Sara Monti et al.   Frontiers in Medicine

Prevalence and prognostic factors for aortic dilatation in giant cell arteritis – a longitudinal study

(2020) Philipp Jud et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Diagnostic Accuracy of PET/CT Scan of the Head, Neck and Chest for Giant Cell Arteritis: The Double-Blinded Giant Cell Arteritis and PET Scan (GAPS) Study

(2019) Anthony M Sammel et al.   Arthritis & Rheumatology

Positive ultrasound halo sign of temporal arteries due to amyloidosis

(2019) Juan Molina Collada et al.   RHEUMATOLOGY

2018 Update of the EULAR recommendations for the management of large vessel vasculitis

(2019) Bernhard Hellmich et al.   ANNALS OF THE RHEUMATIC DISEASES

[18F]FDG positron emission tomography and ultrasound in the diagnosis of giant cell arteritis: congruent or complementary imaging methods?

(2019) Stephan Imfeld et al.   RHEUMATOLOGY

PET/MRI in large-vessel vasculitis: clinical value for diagnosis and assessment of disease activity

(2019) Charlotte Laurent et al.   Scientific Reports

Diagnostic accuracy of ultrasound for detecting large-vessel giant cell arteritis using FDG PET/CT as the reference

(2019) Berit Dalsgaard Nielsen et al.   RHEUMATOLOGY

False positives in the ultrasound diagnosis of giant cell arteritis: some diseases can also show the halo sign

(2019) Elisa Fernández-Fernández et al.   RHEUMATOLOGY

EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice

(2018) Christian Dejaco et al.   ANNALS OF THE RHEUMATIC DISEASES

Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy

(2018) Berit Dalsgaard Nielsen et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Assessing Vasculitis in Giant Cell Arteritis by Ultrasound: Results of OMERACT Patient-based Reliability Exercises

(2018) Valentin S. Schäfer et al.   JOURNAL OF RHEUMATOLOGY

Mortality causes and trends associated with giant cell arteritis: analysis of the French national death certificate database (1980–2011)

(2018) Achille Aouba et al.   RHEUMATOLOGY

18 F-Fluorodeoxyglucose-Positron Emission Tomography As an Imaging Biomarker in a Prospective, Longitudinal Cohort of Patients With Large Vessel Vasculitis

(2018) Peter C. Grayson et al.   Arthritis & Rheumatology

Simple dichotomous assessment of cranial artery inflammation by conventional 18F-FDG PET/CT shows high accuracy for the diagnosis of giant cell arteritis: a case-control study

(2018) Berit Dalsgaard Nielsen et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Diagnostic Utility of Computed Tomographic Angiography in Giant-Cell Arteritis

(2018) Richard Conway et al.   STROKE

The role of colour doppler ultrasonography of facial and occipital arteries in patients with giant cell arteritis: A prospective study

(2017) Rok Ješe et al.   EUROPEAN JOURNAL OF RADIOLOGY

Trial of Tocilizumab in Giant-Cell Arteritis

(2017) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Atherosclerosis as a potential pitfall in the diagnosis of giant cell arteritis

(2017) Eugenio De Miguel et al.   RHEUMATOLOGY

Ultrasound cut-off values for intima-media thickness of temporal, facial and axillary arteries in giant cell arteritis

(2017) Valentin S. Schäfer et al.   RHEUMATOLOGY

The natural history of Chlamydia trachomatis infection in women: a multi-parameter evidence synthesis

(2016) Malcolm J Price et al.   HEALTH TECHNOLOGY ASSESSMENT

The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis?

(2015) Andreas P. Diamantopoulos et al.   RHEUMATOLOGY

Prevalence of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica

(2015) Javier Narváez et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case–control study

(2014) Sergio Prieto-González et al.   ANNALS OF THE RHEUMATIC DISEASES

2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations

(2014) Désirée van der Heijde et al.   ANNALS OF THE RHEUMATIC DISEASES

Facial nerve injury during temporal artery biopsy

(2014) AR Gunawardene et al.   ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND

The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK

(2013) Joanna C Robson et al.   ANNALS OF THE RHEUMATIC DISEASES

Prospective long term follow-up of a cohort of patients with giant cell arteritis screened for aortic structural damage (aneurysm or dilatation)

(2013) Ana García-Martínez et al.   ANNALS OF THE RHEUMATIC DISEASES

Diagnostic Value of Color Doppler Ultrasonography of Temporal Arteries and Large Vessels in Giant Cell Arteritis: A Consecutive Case Series

(2013) Andreas P. Diamantopoulos et al.   ARTHRITIS CARE & RESEARCH

An echocardiographic finding leading to the diagnosis of giant cell arteritis

(2013) P.-J. Palmers et al.   European Heart Journal-Cardiovascular Imaging

Development of aortic aneurysm/dilatation during the followup of patients with giant cell arteritis: A cross-sectional screening of fifty-four prospectively followed patients

(2008) Ana García-Martínez et al.   ARTHRITIS AND RHEUMATISM

Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis

(2008) D. Blockmans et al.   RHEUMATOLOGY